Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
"Build Momentum, Build Adoption"
The post argues that surgeon awareness creates interest, which leads to adoption and ultimately reshapes orthopedic markets. OTW positions itself as a catalyst by showcasing research to the most influential spine surgeons. It invites researchers to submit their work through Jayme Johnson to accelerate momentum. The message frames research dissemination as a strategic lever for market change.
FDA Approves JenaValve TAVR System for Aortic Regurgitation
JenaValve received FDA clearance for its Trilogy Transcatheter Heart Valve System, marking the first TAVR device expressly approved to treat symptomatic, severe aortic regurgitation (AR). The approval follows the ALIGN‑AR trial, which demonstrated the valve’s safety and efficacy in a...
Can AI Help Healthcare Systems Make Sense of Their Data?
At DevSparks 2026, Partex.AI unveiled a sovereign healthcare foundation model that combines federated learning, knowledge graphs, and agentic AI to analyze fragmented medical data without moving patient records. The architecture keeps data on‑site, sharing only encrypted model updates, while knowledge...
Mass General Brigham Health Plan Launches Interactive Wellness Hub
Mass General Brigham Health Plan partnered with mPulse to launch an interactive wellness hub for commercial, Medicare Advantage, Medicaid and dual‑eligible members. The platform uses predictive analytics to deliver personalized nutrition, activity, sleep and stress‑management tools through audio, visual and...
Valbenazine
Valbenazine (Ingrezza®), an oral selective VMAT2 inhibitor from Neurocrine Biosciences, received FDA approval for treating tardive dyskinesia and Huntington’s disease‑associated chorea. In the Phase 3 KINECT‑3 trial, a once‑daily 80 mg dose produced a statistically significant reduction in AIMS dyskinesia scores after...
STAT+: A Huntington’s Researcher on the UniQure-FDA Fray
UniQure’s experimental gene‑therapy for Huntington’s disease, which previously reported a 75% slowdown in disease progression, has received a third consecutive rejection from the FDA. The trial’s lead investigator, Ed Wild of University College London, praised the early data but warned...
Aetna’s New Automatic Algorithm for Paying Doctors Less
Aetna has introduced a black‑box algorithm that automatically downcodes physician claims, lowering payments for high‑severity ER visits without chart review. The system reclassifies Level 5 services to Level 4, forcing doctors to submit appeals to the same insurer that made the reduction....
'Ambulance Desert': Ala. Legislators Push Bill to Fix Rural EMS Crisis
Alabama lawmakers are advancing HB 269 and its companion HB 400 to overhaul ambulance reimbursement rates and allow "treat‑in‑place" billing, aiming to keep rural EMS providers financially viable. The measures respond to an "ambulance desert" landscape where response times can exceed an...
AI Startup Basecamp Research Announces Trillion-Gene Project
Basecamp Research, an AI‑focused biotech startup backed by Microsoft and Nvidia, announced a trillion‑gene sequencing initiative. The company aims to collect genetic sequences for over a trillion proteins within the next two years. Leveraging high‑performance cloud computing and advanced generative‑AI...
Hire Experienced Tech Auditor for Healthcare Apps, HIPAA Compliance Critical
If you are vibe-coding apps for the healthcare sector I beg you - pay a deeply experienced technologist to audit it before anyone uses it. hipaa laws are no joke. I’ve personally been through the compliance audits, defending our encryption...
This Is How Reproductive Rights Are Lost
A Tennessee bill that would have treated abortion as criminal homicide failed to advance, not because of public opposition but due to procedural inaction. The proposal, which could have exposed women to the death penalty, highlights how even the most...
Dr. Paul Marik Offers New Hope for Cancer Patients
Dr. Paul Marik, known for his outspoken views on pandemic policy, has launched a Substack newsletter dedicated to cancer prevention and treatment. The newsletter emphasizes simple lifestyle and dietary changes, especially vitamin D adequacy, as ways to lower cancer risk....
Epic Secures a £222m Federated EPR Contract Across Somerset and Dorset
In early March 2026 four NHS trusts in Somerset and Dorset signed a £222 million federated contract with US‑based Epic to replace a patchwork of legacy electronic patient record (EPR) and patient‑administration systems. The deal unifies Epic’s platform across Somerset NHS...
Ionis Delays Prion Disease Readout; Arvinas' Parkinson's Biomarker Data
Ionis Therapeutics announced that the primary completion date for its Phase 1/2a prion disease trial has been pushed to February 2027, extending the study timeline by more than two years. In parallel, Arvinas reported new biomarker data from its Parkinson’s disease program,...
Video Wednesday
On November 20, 2020 Johnson & Johnson’s Verb division unveiled OTTAVA, a six‑armed robotic platform designed for minimally invasive surgery. The system combines modular hardware with AI‑driven control to perform simultaneous tasks, promising greater precision and efficiency. Early trials indicate up to...
Geroscience Should Prioritize Healthspan, Not Just Lifespan
From a clinical perspective, patients are not asking for abstract years. They are asking for time with family, time in full cognition, time in independence, and time living on their own terms. That is why geroscience should be judged not...
Rox Heart Radio: On the Cusp of ACC 2026
Incoming ACC President Roxana Mehran discusses the upcoming 2026 ACC meeting in New Orleans on the Rox Heart Radio podcast. She outlines her vision for the organization, emphasizing data‑driven leadership, patient‑centered outcomes, and broader member engagement. The episode highlights strategic...
Kennedy’s Vaccine Agenda Stalled, Structure’s ‘Competitive’ Obesity Pill, Novo’s Warning Letter
Structure Therapeutics reported a 16.3% weight loss after 44 weeks in a Phase 2 trial of its oral GLP‑1 pill, positioning it as a competitive alternative to Eli Lilly’s and Novo Nordisk’s candidates. Rhythm Pharmaceuticals disclosed that its obesity drug Imcivree failed in...
Briggs Morrison's Crossbow Unveils $77M Series B for T Cell Engagers
Crossbow Therapeutics, founded by biotech veteran Briggs Morrison, announced a $77 million Series B round to accelerate its off‑the‑shelf T‑cell engager platform. The funding, led by a mix of venture capital and strategic investors, will support the advancement of three preclinical candidates...
Aspen's Personalized Parkinson's Therapy Shows Early Promise
Aspen Neuroscience reported encouraging early data from a small autologous cell therapy trial for Parkinson's disease. The treatment, derived from each patient's own skin cells and reprogrammed into dopaminergic neurons, was safely implanted in twelve participants, showing graft survival and...
Life After Chemsex
Tommy Macnally, now a recovery worker at Antidote, recounts his eight‑year descent into chemsex—a subculture of drug‑enhanced sex among GBMSM—followed by a painful but successful sobriety journey. National data show drug‑poisoning deaths are 2.8 times higher for LGBTQ+ people, with London...
Liver Failure From Alternative Medicines
A recent Indian study of 91 patients exposed to alternative medicines found that 39.6% developed acute‑on‑chronic liver failure (ACLF), with a 38.9% mortality rate among those cases. Heavy‑metal contamination exceeded WHO limits in many products, and 27.7% contained undeclared pharmaceutical...
First MHRA/NICE Aligned Guidance Due in June
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) will begin delivering aligned guidance in June, enabling simultaneous licensing and reimbursement decisions for new medicines. Twenty‑seven companies have signed up...
Nearly Half of All Health Spending in U.S. Comes From 5% of Population
A new KFF analysis of the 2023 Medical Expenditure Panel Survey shows that just 5% of Americans accounted for nearly half of all health spending, with an average outlay of $72,918 per person. The top 1% spent about $150,467 annually....
As Chinese Biotechs Recognize Their Value, the Bargain Era May Be Over
Chinese biotech licensing activity surged in 2025, with 92 deals—a jump from 64 the prior year—and total deal value reaching a record $137.7 billion. The average upfront payment climbed from $102 million to $141 million, signaling that Chinese assets are no longer deep‑discount...
STAT+: J&J Wins Approval for First-of-Its-Kind Psoriasis Pill
Johnson & Johnson received FDA clearance for Icotyde, the first oral daily pill for moderate‑to‑severe plaque psoriasis. The drug, originally called icotrokinra, is approved for patients aged 12 and older and is designed to replicate the efficacy of injectable biologics...
Re: Meningitis: Fatal Outbreak in Kent Is Less Targeted Strain B, Officials Confirm
Public health officials confirmed a fatal meningococcal group B outbreak in Kent, highlighting a less‑targeted strain. The letter notes that vaccination coverage among university students has slipped since the COVID‑19 pandemic, increasing vulnerability in high‑density campuses. It urges routine provision of...
Invest Now: Top 24 Digital Health Tech Trends
AI and Digital Health are booming. In this book, we explain why now it's a good time to invest in Digital Health and give recommendations on where to invest by looking at the top 24 technological trends we find the...
Myriad Genetics Receives the US FDA Approval for MyChoice CDx Test as a Companion Diagnostic for GSK’s Zejula
Myriad Genetics announced FDA approval of its MyChoice CDx test as a companion diagnostic for GSK’s Zejula (niraparib) in advanced ovarian cancer. The clearance follows the PRIMA trial, which showed that patients identified as HRD‑positive derived significant benefit from Zejula...
Blog 109a. Cybersecurity Crisis in Healthcare: When AI and Ransomware Shut Down Patient Care.
In 2026 healthcare cyberattacks escalated from IT nuisances to clinical emergencies, with ransomware and system intrusions forcing hospitals to cancel procedures and revert to manual processes. The convergence of AI-driven tools and sophisticated ransomware amplified attack vectors, making recovery slower...
Mitochondria Packaged in Blood Cell Membranes Improve Disease Symptoms in Mice
Researchers have engineered microscopic capsules made from red blood cell membranes that encase single, healthy mitochondria and can be injected into animals. In mouse models of Parkinson‑like disease and Leigh syndrome, the capsules restored neuronal function, improved motor activity, and...
Seaweed Shield: Marine Molecules May Block Norovirus Infection
Researchers from Griffith University and biotech firm Marinova evaluated brown and green seaweed polysaccharides for their ability to block norovirus attachment. Fucoidan, a sulfated fiber from brown seaweed, demonstrated the strongest and most consistent inhibition of virus‑like particles binding to...
Medical Residents Endure Toxic Culture, Power Imbalance Fuels Burnout
Medical residents are the backbone of the hospital system. They are also its favorite punching bag. We expect them to work 80 hour weeks. We expect them to accept low pay. But we also force them to endure systemic disrespect, microaggressions,...
Comparing Psychedelic Trials to Antidepressants Skews Results
Does it stack the deck in favor of the standard antidepressants to pull data from placebo-controlled trials for one condition (the psychedelic) and compare it with single condition data for the standard antidepressants? Also...
Samsung Bioepis Partners with Sandoz for Up to Five Biosimilar Candidates
Samsung Bioepis and Sandoz have signed a global license, development and commercialization agreement covering up to five biosimilar candidates, including the preclinical SB36 biosimilar to Entyvio (vedolizumab). Samsung Bioepis will manage development, manufacturing and regulatory submissions, while Sandoz will handle...
AI in Healthcare Fails Without a Digital Strategy
80% of healthcare practices that invest in AI automation fail to see ROI. Not because the tools don't work, but because there was no digital strategy. Don't be the 80% See more & JoinUs https://t.co/05FgGDavR7 #healthcare #ai #businessautomation #smallbusiness #medical #doctor...
Profiting From Out‑of‑Network Bills, and the Fury It Sparks
How to get rich on out-of-network medical bills -- and how to get angry reading about it. By @TaraBannow https://t.co/fbmFyZhcic
Your Next Hospital Stay Might Be In Your Own Bedroom. A Doctor Explains
Medicare’s Acute Hospital Care at Home waiver has been extended through September 2030, giving hospitals a decade‑long runway to expand home‑based acute care. As of September 2025, 419 hospitals in 39 states are authorized, treating conditions such as pneumonia, heart‑failure,...
Excalipoint Secures $69M for Next‑Gen T‑Cell Engagers
Chinese biotech startup Excalipoint banks $69M for next-gen T cell engagers https://t.co/809RqRWJNL by @gwendolynawu #biotech #startups
Re: Seeing Healthcare From Both Sides of the Bedrail
A junior doctor at age 25 was diagnosed with an aggressive stage‑II sarcoma after her initial request for imaging was denied because her symptoms did not fit classic cancer criteria. The delay highlighted how strict adherence to typical presentation guidelines...
US Court Says Pharma Giants Must Face False Claims Suit
The U.S. Ninth Circuit Court of Appeals denied dismissal motions by AbbVie, AstraZeneca, Novartis and Sanofi, allowing a whistleblower False Claims Act suit over alleged 340B program overcharges to proceed. The lawsuit, filed by Adventist Health System/West, claims the manufacturers...
Insurer and Business Lobbying Interests Kill Supplemental Breast Imaging Bill in 1 State
Kansas Senate Bill 409, which would mandate insurers to cover supplemental breast imaging after mammography, failed to advance as the legislative session progressed. Insurer Blue Cross and business groups such as the Kansas Chamber of Commerce opposed the bill, labeling...
Malaysian Medical Tourism Set to Benefit From Iran War’s Impact
Malaysia’s medical tourism could gain patients from the Middle East as the Iran‑Israel conflict makes Dubai’s medical hub unsafe. Sunway Healthcare’s president warned that regional travelers may seek temporary stays in Southeast Asia, especially Malaysia. Revenue from medical tourists rose...
Hospice CARE Act Reintroduced
Rep. Linda T. Sánchez and Sen. Mark Warner have re‑introduced the Hospice CARE Act, aiming to modernize the Medicare hospice benefit while tightening program integrity. The legislation proposes a moratorium on new hospice enrollment, enhanced transparency of ownership, and higher...
Rollout of Ambient Voice Technology Across UHL-UHN to Speed up Care and Improve Communication for Patients
The University Hospitals of Leicester (UHL) and University Hospitals of Northamptonshire (UHN) have become the first NHS trusts to jointly deploy AI‑powered Ambient Voice Technology (AVT) through Accurx Scribe. The rollout will equip more than 10,000 clinicians with voice‑captured scribing...
Xaira Unveils AI Model X-Cell for Predicting Virtual Cells
Xaira, the biotech AI startup with the deepest funding round, launched its first model, X‑Cell, on Tuesday. The platform uses deep learning to generate virtual cell representations from multi‑omics data, enabling researchers to simulate cellular responses without physical experiments. Early...
Evidence Shows ACA’s Mandated Benefits Alone Don’t Drive Up Costs. The Debate Continues.
President Donald Trump has again blamed the Affordable Care Act for rising health‑care costs, citing premium spikes since the law’s rollout. Data show ACA individual premiums have risen 129% since 2014, outpacing the 68% increase in employer‑based plans, while deductibles...
Red States Move to Protect Crisis Pregnancy Centers Using Model Legislation
Conservative lawmakers in Wyoming, Kansas and Oklahoma are advancing the Alliance Defending Freedom’s model CARE Act, which shields crisis pregnancy centers from state mandates to provide abortion referrals, information or contraception. The bill also grants centers the right to sue...
Susie Wiles with Breast Cancer, AAP Et Al Prevails on ACIP, Look to States for Vaccine Freedom
In this episode of Just the News No Noise, Dr. Peter McCullough discusses Susie Wiles’ early‑stage breast cancer, suggesting speculative links to COVID‑19 vaccines and recommending tissue testing for spike protein. He then critiques a federal judge’s decision blocking vaccine‑schedule reforms championed...
How to Switch Between Health Insurance Plans in India Without Losing Benefits
Switching health insurance plans in India can be done without losing benefits by using the portability option at renewal. The article outlines a step‑by‑step process that emphasizes timing, documentation, and full health disclosure to retain waiting‑period credits and existing‑condition coverage....